|
Real-time Estimate
Cboe BZX
12:09:48 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 2.275 USD | -3.60% |
|
-7.52% | +26.39% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.60% | -7.52% | -1.52% | +13.75% | +26.39% | +49.67% | +14.32% | +72.35% | -64.89% | 190M | |
| -1.83% | +0.03% | +2.91% | +17.82% | +10.37% | +73.30% | +120.47% | +339.40% | +1,377.84% | 1,078B | |
| -0.60% | +0.37% | +2.50% | +12.74% | +25.73% | +48.92% | +50.02% | +46.31% | +112.74% | 632B | |
| -0.43% | +1.26% | +1.78% | +18.20% | +9.03% | +21.72% | +63.61% | +110.40% | +269.68% | 443B | |
| -1.99% | -3.32% | +8.59% | +10.01% | +8.20% | +41.98% | +34.08% | -3.60% | +42.73% | 356B | |
| -1.05% | -2.81% | +0.02% | +4.94% | +11.72% | +24.22% | +34.67% | +42.52% | +52.48% | 289B | |
| -2.12% | -3.67% | -7.31% | -16.59% | -16.90% | -1.09% | +3.11% | +35.19% | +122.78% | 245B | |
| -1.32% | +0.24% | +15.96% | +22.52% | +25.86% | +41.91% | +57.85% | +78.27% | +135.96% | 226B | |
| -1.19% | -3.41% | -7.82% | +3.04% | -9.39% | -9.18% | -52.41% | -9.17% | +89.40% | 204B | |
| -0.25% | +3.47% | +5.99% | +4.37% | +12.29% | +15.80% | +72.61% | +92.20% | +73.04% | 171B | |
| -0.09% | -0.06% | +10.29% | +3.86% | +7.41% | +6.51% | -25.85% | -45.32% | -23.83% | 153B | |
| -1.47% | +2.34% | +6.59% | +12.72% | +11.98% | +30.08% | +45.32% | +165.85% | +395.40% | 131B | |
| -1.21% | -1.51% | +11.92% | +12.28% | +18.17% | +33.32% | +3.44% | -7.19% | +6.18% | 132B | |
| -1.19% | +0.28% | +0.03% | +3.11% | -8.70% | -9.60% | -22.63% | -14.23% | +5.20% | 106B | |
| -2.10% | -7.29% | -5.36% | -2.94% | -0.38% | +28.45% | +31.13% | -3.01% | -15.07% | 100B | |
| -3.37% | +2.50% | -4.11% | -11.17% | -15.89% | +10.84% | +62.52% | +68.77% | +465.19% | 74.07B | |
| +0.94% | +3.43% | +5.51% | +8.07% | +16.05% | +28.78% | +26.03% | +52.72% | +16.70% | 55.7B | |
| -0.56% | -4.06% | -2.71% | +25.17% | +29.13% | +79.46% | -9.33% | +0.07% | -51.55% | 54.47B | |
| -2.12% | +0.98% | -5.61% | -5.80% | -11.67% | -15.96% | +34.23% | -6.92% | +216.83% | 52.51B | |
| -0.64% | -3.74% | -1.30% | +8.05% | -5.12% | -0.64% | +5.38% | - | - | 42.55B | |
| Average | -1.30% | +0.86% | +1.82% | +7.21% | +7.21% | +24.92% | +27.43% | +53.40% | +169.83% | 227.25B | |
| Weighted average by Cap. | -1.25% | +1.33% | +2.82% | +10.48% | +9.74% | +37.09% | +52.40% | +114.36% | +419.64% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
